Cytoreductive Surgery
Surgical Oncology

Get to Know Dr. Dan G. Blazer III

Surgical oncologist Dr. Dan G. Blazer III specializes in the combination treatment of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, known as HIPEC, that has proven so effective in treating patients with peritoneal mesothelioma.

Blazer, an associate professor of surgery, directs the Complex General Surgical Oncology and Hepatopancreatobiliary fellowship programs at the Duke University School of Medicine.

He joined Duke University in 2008, following in the footsteps of his father, a staff psychiatrist for almost 40 years. Blazer specializes in the surgical management of gastrointestinal malignancies, which includes advanced-stage colorectal, pancreatic and gastric cancers.

His cancer cases are heard before a multidisciplinary tumor board, ensuring all treatment options are considered.

Blazer’s expertise in the HIPEC procedure, which is done only in specialized treatment centers around the country, has helped extend survival dramatically for those with peritoneal malignancies.

Outside the clinic, he focuses on translational research, working to develop a more personalized approach to treatment.

Specialties of Dr. Dan G. Blazer III

  • Gastrointestinal malignancies
  • Peritoneal mesothelioma
  • Cytoreductive surgery
  • Whipple surgery
  • Multimodality approach to treatment

Dr. Dan G. Blazer III’s Experience and Medical Education

  • Duke Cancer Center
  • MD Anderson Cancer Center, National Cancer Institute (Fellowships)
  • University of Michigan Medical Center (Residency)
  • Duke University School of Medicine (M.D.)

Dr. Dan G. Blazer III’s Awards and Certifications

  • American Board of Surgery (General surgery)
  • Surgical Fellowship Awards

Publications of Dr. Dan G. Blazer III

  • Lazarides, A. et al. (2020, July 21). Defining a textbook surgical outcome for patients undergoing surgical resection of intermediate and high‐grade soft tissue sarcomas of the extremities. Journal of Surgical Oncology.
  • Schmitz, R. et al. (2020, July 1). ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas. Annals of Surgical Oncology.
  • Moris, D. et al. (2018, February). Neuroendocrine Neoplasms of the Appendix: A Review of the Literature. Anticancer Research.